Zim Laboratories

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue77.4786.72105.0692.7599.40
Expenses71.5679.8794.4985.8391.51
EBITDA5.916.8510.576.927.89
EBIT1.553.026.392.653.52
Profit Before Tax4.205.7810.777.487.95
Net Profit3.264.077.035.155.45
Financial Ratios
Operating Profit Margin7.63%7.90%10.07%7.45%7.94%
Net Profit Margin4.21%4.69%6.69%5.55%5.48%
Earning Per Share (Diluted)2.002.514.333.173.35
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.5.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI